Onco Med Pharmaceuticals
Biotechnology, 800 Chesapeake Dr., Redwood City, California, 94063, United States, 51-200 Employees
Phone Number: +17*********
Who is ONCOMED PHARMACEUTICALS
OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor ini...
Read More
-
Headquarters: 800 Chesapeake Dr., Redwood City, California, 94063, United States
-
Date Founded: 2004
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ONCOMED PHARMACEUTICALS
OncoMed Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding OncoMed Pharmaceuticals
Answer: OncoMed Pharmaceuticals's headquarters are located at 800 Chesapeake Dr., Redwood City, California, 94063, United States
Answer: OncoMed Pharmaceuticals's phone number is +17*********
Answer: OncoMed Pharmaceuticals's official website is https://oncomed.com
Answer: OncoMed Pharmaceuticals's revenue is $50 Million to $100 Million
Answer: OncoMed Pharmaceuticals's SIC: 2834
Answer: OncoMed Pharmaceuticals's NAICS: 325412
Answer: OncoMed Pharmaceuticals has 51-200 employees
Answer: OncoMed Pharmaceuticals is in Biotechnology
Answer: OncoMed Pharmaceuticals contact info: Phone number: +17********* Website: https://oncomed.com
Answer: OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month